News of Note—Pfizer, Meridian Medical Technologies, EpiPen, saline shortage

Newspapers

> Pfizer, which previously received a warning letter for the Meridian Medical Technologies plant that makes EpiPen injectors for Mylan, has reported to Health Canada that manufacturing problems have led to a shortage of the 0.3 mg format of the pen which it expects to have resolved by March 2, 2018. Release

> The FDA says that the shortage of saline has now led to a shortage of empty IV bags which healthcare providers have been using for compounded versions of the solution. Release

INDUSTRY RESEARCH

Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

> Wuhan Chinese Moxibustion Technology Dev. Co., a maker of an updated version of a traditional Chinese medicine, has received an FDA warning letter for GMP failures at its plant in Wuhan, Hubei, China. Letter